Akari Therapeutics (AKTX) Return on Assets (2015 - 2026)

Akari Therapeutics (AKTX) has 11 years of Return on Assets data on file, last reported at 0.01% in Q1 2026.

• For the quarter ending Q1 2026, Return on Assets changed 0.0% year-over-year to 0.01%; the trailing twelve-month figure through Mar 2026 stood at 0.01% (changed 0.0% YoY), and the FY2025 full-year result was 0.0%, changed 0.0% from the prior year.
• Return on Assets retreated to 0.01% in Q1 2026, from 0.0% in the prior quarter.
• In the past five years, Return on Assets ranged from a high of 0.0% in Q2 2025 to a low of 0.05% in Q3 2024.
• A 4-year average of 0.02% and a median of 0.01% in 2022 frame the typical range for Return on Assets.
• Across the five-year window, Return on Assets changed 0 bps in 2022 and gained 5 bps in 2025, its largest moves.
• Tracing AKTX's Return on Assets over 4 years: stood at 0.01% in 2022, then sank by 35 bps to 0.01% in 2024, then soared by 47 bps to 0.0% in 2025, then slumped by 80 bps to 0.01% in 2026.
• Business Quant data shows AKTX's Return on Assets at 0.01% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.